Amkay Products Ltd

Amkay Products Limited's Board of Directors approved the audited financial results for the half year and year ended March 31, 2026. The company reported a total revenue from operations of ₹4202.70 Lakhs for FY26, an increase from ₹3839.01 Lakhs in FY25. Total assets and liabilities stood at ₹3331.04 Lakhs as of March 31, 2026, up from ₹2988.68 Lakhs in the previous year. Reserves and surplus grew to ₹1772.05 Lakhs from ₹1540.95 Lakhs. The Board also appointed M/s. Soni Punit & Associates as the Internal Auditor for FY 2026-27. The trading window for the company's securities will open after 48 hours of the results being made public.

Amkay Products Limited's Board of Directors met on May 28, 2026, and approved the audited financial results for the half year and full year ended March 31, 2026. The board also appointed M/s. Soni Punit & Associates as the Internal Auditor for the financial year 2026-27. The trading window for the company's securities will open 48 hours after the results are made public. The meeting took place from 4:00 p.m. to 5:10 p.m.

Amkay Products Ltd has scheduled a Board of Directors meeting on May 28, 2026, to consider and approve the Audited Financial Results for the year ended March 31, 2026. The board will also consider the appointment of an Internal Auditor for the F.Y. 2026-27. The trading window, which closed on April 1, 2026, will reopen 48 hours after the results are made public.

Amkay Products Ltd, in accordance with SEBI (Prohibition of Insider Trading) Regulation, 2015 and BSE Circular No. LIST/COMP/01/2019-20, has announced the closure of the trading window for all designated persons. The closure will be in effect from Wednesday, 01st April, 2026 till the expiry of 48 hours after the declaration of financial results for the financial year ended 31st March, 2026. This decision is a part of the company's commitment to maintain transparency and fairness in its trading activities.

Amkay Products Ltd has clarified the price movement of its shares on the Bombay Stock Exchange (BSE). The company stated that it has consistently disclosed all price sensitive information to the BSE as required by the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The movement in the company's share price is attributed to market conditions and not due to any internal factors. Amkay Products Ltd reiterates its commitment to adhering to the disclosure regulations and will continue to inform the BSE of any required information.

Amkay Products Ltd has announced that its Board of Directors will meet on November 12, 2025 to consider and approve the unaudited financial results for the half year ended on September 30, 2025. The meeting will be conducted through video conferencing/other audio visual means (VC/OAVM). The trading window for dealing in the securities of the Company by the specified persons was closed on October 1, 2025 and will end after 48 hours of the results are made public on November 12, 2025.

Amkay Products Ltd has announced the closure of the trading window for all designated persons in accordance with the SEBI (Prohibition of Insider Trading) Regulation, 2015 and BSE Circular No. LIST/COMP/01/2019-20. The closure is effective from Wednesday, 015t October, 2025 until 48 hours after the declaration of the half-yearly financial results for the period ended 30 September, 2025.

Amkay Products Ltd, a manufacturer of medical devices and disposables, has released its Annual Report for the financial year 2024-25. The company has announced its 18th Annual General Meeting (AGM) to be held on Monday, 29th September, 2025 at 12.00 p.m. The report includes the Management Discussion and Analysis, Company Overview, Board's Report, Independent Auditor’s Report on Financial Statements, and Standalone Financials. The company's Board of Directors, Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship & Grievance Committee are also listed in the report.

Amkay Products Ltd, a Mfg. of Medical Devices & Disposables, announced its audited financial results for the half year and year ended March 31, 2025. The meeting was held on Friday, 23rd May, 2025 and also included the appointment of M/s. Pimple & Associates as a Secretarial Auditor for the F.Y. 2025-26 and M/s. Soni Punit & Associates as an Internal Auditor of the Company for the F.Y. 2025-26. The trading window for dealing in the securities of the Company will open after 48 hours of the results being made public.

Amkay Products Limited, a Mfg. of Medical Devices & Disposables, held a Board Meeting on 23rd May, 2025. The meeting, conducted through VC/OAVM, approved the audited financial results for the half year and year ended March 31, 2025. The company also appointed M/s. Pimple & Associates as Secretarial Auditor and M/s. Soni Punit & Associates as Internal Auditor for the F.Y. 2025-26. The trading window for dealing in the securities of the Company will open after 48 hours of the results being made public on Friday, 23rd May, 2025.